
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer
Ling Li, Tao Zhu, Yuanfeng Gao, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 6, pp. 839-839
Open Access | Times Cited: 57
Ling Li, Tao Zhu, Yuanfeng Gao, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 6, pp. 839-839
Open Access | Times Cited: 57
Showing 1-25 of 57 citing articles:
Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance
Adnin Ashrafi, Zakia Akter, Pouya Modareszadeh, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4562-4562
Open Access | Times Cited: 70
Adnin Ashrafi, Zakia Akter, Pouya Modareszadeh, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4562-4562
Open Access | Times Cited: 70
Small-molecule inhibition of APE1 induces apoptosis, pyroptosis, and necroptosis in non-small cell lung cancer
Kaili Long, Lili Gu, Lulu Li, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 102
Kaili Long, Lili Gu, Lulu Li, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 102
TGFβ pathway inhibition in the treatment of non-small cell lung cancer
Pınar Ö. Eser, Pasi A. Jänne
Pharmacology & Therapeutics (2017) Vol. 184, pp. 112-130
Closed Access | Times Cited: 95
Pınar Ö. Eser, Pasi A. Jänne
Pharmacology & Therapeutics (2017) Vol. 184, pp. 112-130
Closed Access | Times Cited: 95
miR-410 induces both epithelial–mesenchymal transition and radioresistance through activation of the PI3K/mTOR pathway in non-small cell lung cancer
Yuan Yue, Hu Liao, Qiang Pu, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 71
Yuan Yue, Hu Liao, Qiang Pu, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 71
The regulatory function of piRNA/PIWI complex in cancer and other human diseases: The role of DNA methylation
Dong‐Dong Jia, Hui Jiang, Yifei Zhang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 8, pp. 3358-3373
Open Access | Times Cited: 55
Dong‐Dong Jia, Hui Jiang, Yifei Zhang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 8, pp. 3358-3373
Open Access | Times Cited: 55
The role of HIF-1α in chemo-/radioresistant tumors
Yu Xia, Lixia Jiang, Tianyu Zhong
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 3003-3011
Open Access | Times Cited: 82
Yu Xia, Lixia Jiang, Tianyu Zhong
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 3003-3011
Open Access | Times Cited: 82
MALAT1-miR-101-SOX9 feedback loop modulates the chemo-resistance of lung cancer cell to DDP via Wnt signaling pathway
Wei Chen, Wei Zhao, Li Zhang, et al.
Oncotarget (2017) Vol. 8, Iss. 55, pp. 94317-94329
Open Access | Times Cited: 73
Wei Chen, Wei Zhao, Li Zhang, et al.
Oncotarget (2017) Vol. 8, Iss. 55, pp. 94317-94329
Open Access | Times Cited: 73
Houttuynia cordata Thunb. and its bioactive compound 2-undecanone significantly suppress benzo(a)pyrene-induced lung tumorigenesis by activating the Nrf2-HO-1/NQO-1 signaling pathway
Yanmei Lou, Zhenzhen Guo, Yuanfeng Zhu, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 73
Yanmei Lou, Zhenzhen Guo, Yuanfeng Zhu, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 73
lncRNA‐NKILA /NF ‐κB feedback loop modulates laryngeal cancer cell proliferation, invasion, and radioresistance
Tao Yang, Shisheng Li, Jiajia Liu, et al.
Cancer Medicine (2018) Vol. 7, Iss. 5, pp. 2048-2063
Open Access | Times Cited: 72
Tao Yang, Shisheng Li, Jiajia Liu, et al.
Cancer Medicine (2018) Vol. 7, Iss. 5, pp. 2048-2063
Open Access | Times Cited: 72
The Role of Long Non Coding RNAs in the Repair of DNA Double Strand Breaks.
Ali Dianatpour, Soudeh Ghafouri‐Fard
PubMed (2017) Vol. 6, Iss. 1, pp. 1-12
Closed Access | Times Cited: 55
Ali Dianatpour, Soudeh Ghafouri‐Fard
PubMed (2017) Vol. 6, Iss. 1, pp. 1-12
Closed Access | Times Cited: 55
Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors
Mehlika Dilek Altıntop, Belgin Sever, Gülşen Akalın Çiftçi, et al.
Molecules (2018) Vol. 23, Iss. 6, pp. 1318-1318
Open Access | Times Cited: 54
Mehlika Dilek Altıntop, Belgin Sever, Gülşen Akalın Çiftçi, et al.
Molecules (2018) Vol. 23, Iss. 6, pp. 1318-1318
Open Access | Times Cited: 54
The role of single strand break repair pathways in cellular responses to camptothecin induced DNA damage
Chao Mei, Lin Lei, Liming Tan, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 125, pp. 109875-109875
Open Access | Times Cited: 44
Chao Mei, Lin Lei, Liming Tan, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 125, pp. 109875-109875
Open Access | Times Cited: 44
Long non-coding RNAs associated with non-small cell lung cancer
Yuting Zhan, Hongjing Zang, Juan Feng, et al.
Oncotarget (2017) Vol. 8, Iss. 40, pp. 69174-69184
Open Access | Times Cited: 44
Yuting Zhan, Hongjing Zang, Juan Feng, et al.
Oncotarget (2017) Vol. 8, Iss. 40, pp. 69174-69184
Open Access | Times Cited: 44
miR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1
Qi Song, Quanbo Ji, Jingbo Xiao, et al.
Molecular Therapy — Nucleic Acids (2018) Vol. 13, pp. 154-163
Open Access | Times Cited: 42
Qi Song, Quanbo Ji, Jingbo Xiao, et al.
Molecular Therapy — Nucleic Acids (2018) Vol. 13, pp. 154-163
Open Access | Times Cited: 42
APE1 controls DICER1 expression in NSCLC through miR-33a and miR-130b
Giulia Antoniali, Emiliano Dalla, Giovanna Mangiapane, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Open Access | Times Cited: 22
Giulia Antoniali, Emiliano Dalla, Giovanna Mangiapane, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Open Access | Times Cited: 22
The correlation between miR-21 single nucleotide polymorphisms and the susceptibility of non-small cell lung cancer
Miao Zhang, Ming Zhang, Ruixue Han, et al.
Journal of Cardiothoracic Surgery (2025) Vol. 20, Iss. 1
Open Access
Miao Zhang, Ming Zhang, Ruixue Han, et al.
Journal of Cardiothoracic Surgery (2025) Vol. 20, Iss. 1
Open Access
Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action
Mehlika Dilek Altıntop, Gülşen Akalın Çiftçi, Nalan Yılmaz Savaş, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2648-2648
Open Access | Times Cited: 10
Mehlika Dilek Altıntop, Gülşen Akalın Çiftçi, Nalan Yılmaz Savaş, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2648-2648
Open Access | Times Cited: 10
Exosomal miR ‐ 196a‐5p enhances radioresistance in lung cancer cells by downregulating NFKBIA
Fei Yao, Wei Shi, Fang Fang, et al.
The Kaohsiung Journal of Medical Sciences (2023) Vol. 39, Iss. 6, pp. 554-564
Open Access | Times Cited: 9
Fei Yao, Wei Shi, Fang Fang, et al.
The Kaohsiung Journal of Medical Sciences (2023) Vol. 39, Iss. 6, pp. 554-564
Open Access | Times Cited: 9
Gamma-ray-responsive drug delivery systems for radiation protection
Ke Zheng, Xinguo Zhu, Shaoyun Guo, et al.
Chemical Engineering Journal (2023) Vol. 463, pp. 142522-142522
Closed Access | Times Cited: 9
Ke Zheng, Xinguo Zhu, Shaoyun Guo, et al.
Chemical Engineering Journal (2023) Vol. 463, pp. 142522-142522
Closed Access | Times Cited: 9
USP14 Regulates DNA Damage Response and Is a Target for Radiosensitization in Non-Small Cell Lung Cancer
Arishya Sharma, Alexandru Almasan
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6383-6383
Open Access | Times Cited: 27
Arishya Sharma, Alexandru Almasan
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6383-6383
Open Access | Times Cited: 27
MiR-21 and let-7 cooperation in the regulation of lung cancer
Jinquan Bai, Zhenzhou Shi, Shuting Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
Jinquan Bai, Zhenzhou Shi, Shuting Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
snoRNA and piRNA expression levels modified by tobacco use in women with lung adenocarcinoma
Natasha Andressa Nogueira Jorge, Gabriel Wajnberg, Carlos Gil Ferreira, et al.
PLoS ONE (2017) Vol. 12, Iss. 8, pp. e0183410-e0183410
Open Access | Times Cited: 27
Natasha Andressa Nogueira Jorge, Gabriel Wajnberg, Carlos Gil Ferreira, et al.
PLoS ONE (2017) Vol. 12, Iss. 8, pp. e0183410-e0183410
Open Access | Times Cited: 27
DNA repair pathways and their roles in drug resistance for lung adenocarcinoma
Altan Kara, Aykut Özgür, Sinem Nalbantoğlu, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 4, pp. 3813-3825
Closed Access | Times Cited: 18
Altan Kara, Aykut Özgür, Sinem Nalbantoğlu, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 4, pp. 3813-3825
Closed Access | Times Cited: 18
A new series of thiazole‐hydrazone hybrids for Akt‐targeted therapy of non‐small cell lung cancer
Turana Orujova, Abdulilah Ece, Gülşen Akalın Çiftçi, et al.
Drug Development Research (2022) Vol. 84, Iss. 2, pp. 185-199
Closed Access | Times Cited: 13
Turana Orujova, Abdulilah Ece, Gülşen Akalın Çiftçi, et al.
Drug Development Research (2022) Vol. 84, Iss. 2, pp. 185-199
Closed Access | Times Cited: 13
Circular RNAs in lung cancer: implications for preventing therapeutic resistance
Wenjuan Liu, Yawen Sun, Yanfei Huo, et al.
EBioMedicine (2024) Vol. 107, pp. 105309-105309
Open Access | Times Cited: 2
Wenjuan Liu, Yawen Sun, Yanfei Huo, et al.
EBioMedicine (2024) Vol. 107, pp. 105309-105309
Open Access | Times Cited: 2